Human Vaccines & Immunotherapeutics: news
- PMID: 32598246
- PMCID: PMC7482739
- DOI: 10.1080/21645515.2020.1778422
Human Vaccines & Immunotherapeutics: news
Similar articles
-
Human Vaccines & Immunotherapeutics: News.Hum Vaccin Immunother. 2017 Jan 2;13(1):9-10. doi: 10.1080/21645515.2017.1278977. Hum Vaccin Immunother. 2017. PMID: 28125379 Free PMC article. No abstract available.
-
Human Vaccines & Immunotherapeutics: News.Hum Vaccin Immunother. 2018 Mar 4;14(3):502-503. doi: 10.1080/21645515.2018.1442961. Hum Vaccin Immunother. 2018. PMID: 29553914 Free PMC article. No abstract available.
-
Human Vaccines & Immunotherapeutics: news.Hum Vaccin Immunother. 2021 Feb 1;17(2):330-331. doi: 10.1080/21645515.2021.1883401. Hum Vaccin Immunother. 2021. PMID: 33606608 Free PMC article. No abstract available.
-
Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market.Appl Microbiol Biotechnol. 2010 Jun;87(2):401-10. doi: 10.1007/s00253-010-2590-7. Epub 2010 Apr 27. Appl Microbiol Biotechnol. 2010. PMID: 20422181 Review.
-
Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers.Front Immunol. 2021 Jan 8;11:586796. doi: 10.3389/fimmu.2020.586796. eCollection 2020. Front Immunol. 2021. PMID: 33488587 Free PMC article. Review.
References
-
- Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C . Rapid development of an inactivated vaccine for SARS-CoV-2. BioRxiv. 2020. doi:10.1101/2020.04.17.046375. - DOI - PMC - PubMed
-
- Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM . Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30248-6. - DOI - PMC - PubMed
-
- Galsky MD, Mortazavi A, Milowsky MI, George S, Gupta S, Fleming MT, Dang LH, Geynisman DM, Walling R, Alter RS, Kassar M, Wang J, Gupta S, Davis N, Picus J, Philips G, Quinn DI, Haines GK 3rd, Hahn NM, Zhao Q, Yu M, Pal SK . Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer. J Clin Oncol. 2020. JCO1903091. - PMC - PubMed
-
- Mansurov A, Ishihara J, Hosseinchi P, Potin L, Marchell TM, Ishihara A, Williford JM, Alpar AT, Raczy MM, Gray LT, Swartz MA, Hubbell JA . Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nat Biomed Eng 2020. doi:10.1038/s41551-020-0549-2. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources